跳至主要内容
临床试验/PACTR202011867644311
PACTR202011867644311尚未招募3 期

Evaluation of High Dose Rifampicin and Dialkylcarbamoyl chloride (DACC)-coated dressings to improve outcomes in Mycobacterium ulcerans disease

ondon School of Hygiene and Tropical Medicine0 个研究点目标入组 112 人开始时间: 2020年11月27日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
112

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 Year(s) 至 12 Year(s)(—)
性别
All

入选标准

  • i.Age between 5 and 80 years old
  • ii.Have a nodule, plaque or ulcer, with or without associated oedema.
  • iii.Lesion that has tested positive for M. ulcerans by Polymerase Chain Reaction (PCR) for IS2404
  • iv.Participant or parent/guardian able to give informed consent.
  • v.Able and willing to follow the protocol requirements

排除标准

  • i.Current participation in any interventional study at the time of randomisation
  • ii.Known allergy to any component of DACC dressing
  • iii.Known contraindication to either Rifampicin or clarithromycin

研究者

发起方
ondon School of Hygiene and Tropical Medicine

相似试验